These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2016709)

  • 1. Inhibition of human placental aromatase by novel homologated 19-oxiranyl and 19-thiiranyl steroids.
    Childers WE; Silverton JV; Kellis JT; Vickery LE; Robinson CH
    J Med Chem; 1991 Apr; 34(4):1344-9. PubMed ID: 2016709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Alkyl- and 6-arylandrost-4-ene-3,17-diones as aromatase inhibitors. Synthesis and structure-activity relationships.
    Numazawa M; Oshibe M
    J Med Chem; 1994 Apr; 37(9):1312-9. PubMed ID: 8176709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
    Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships.
    Numazawa M; Yamaguchi S
    J Steroid Biochem Mol Biol; 1998 Oct; 67(1):41-8. PubMed ID: 9780028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective inhibition of human placental aromatase.
    Childers WE; Shih MJ; Furth PS; Robinson CH
    Steroids; 1987; 50(1-3):121-34. PubMed ID: 3504056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase.
    O'Reilly JM; Li N; Duax WL; Brueggemeier RW
    J Med Chem; 1995 Jul; 38(15):2842-50. PubMed ID: 7636845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of A-ring steroids.
    Johnston JO; Wright CL; Burkhart JP; Peet NP
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):623-31. PubMed ID: 8476773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent inhibition of human placental aromatase with a 2,19-methyleneoxy-bridged androstenedione.
    Peet NP; Burkhart JP; Wright CL; Johnston JO
    J Med Chem; 1992 Aug; 35(17):3303-6. PubMed ID: 1507213
    [No Abstract]   [Full Text] [Related]  

  • 9. Aromatase inhibition by 4 beta,5 beta-epoxides of 16 alpha-hydroxyandrostenedione and its 19-oxygenated analogs, potential precursors of estriol production in the feto-placental unit.
    Numazawa M; Yoshimura A; Watari Y; Matsuzaki H
    Biol Pharm Bull; 2002 Dec; 25(12):1566-9. PubMed ID: 12499641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation.
    Varela C; Tavares da Silva EJ; Amaral C; Correia da Silva G; Baptista T; Alcaro S; Costa G; Carvalho RA; Teixeira NA; Roleira FM
    J Med Chem; 2012 Apr; 55(8):3992-4002. PubMed ID: 22475216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs.
    Numazawa M; Shelangouski M; Nagasaka M
    Steroids; 2000 Dec; 65(12):871-82. PubMed ID: 11077085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 2,2-dimethyl-4-hydroxy-4-androstene-3,17-dione as an inhibitor of aromatase.
    Furth PS; Rosenberger J; Marcotte PA; Robinson CH
    J Enzyme Inhib; 1990; 4(2):131-5. PubMed ID: 2098519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6beta,19-Bridged androstenedione analogs as aromatase inhibitors.
    Komatsu S; Yaguchi A; Yamashita K; Nagaoka M; Numazawa M
    Steroids; 2009 Nov; 74(12):884-9. PubMed ID: 19524602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain.
    Numazawa M; Oshibe M
    Steroids; 1995 Aug; 60(8):506-11. PubMed ID: 8539792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 19-(cyclopropylamino)-androst-4-en-3,17-dione: a mechanism-based inhibitor of aromatase.
    Njar VC; Düerkop J; Hartmann RW
    J Enzyme Inhib; 1996; 10(1):47-56. PubMed ID: 8835929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues.
    Marcotte PA; Robinson CH
    Biochemistry; 1982 May; 21(11):2773-8. PubMed ID: 7093221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships for non-steroidal inhibitors of aromatase.
    Banting L; Smith HJ; James M; Jones G; Nazareth W; Nicholls PJ; Hewlins MJ; Rowlands MG
    J Enzyme Inhib; 1988; 2(3):215-29. PubMed ID: 3241182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture.
    Brueggemeier RW; Katlic NE; Kenreigh CA; Li PK
    J Steroid Biochem Mol Biol; 1992 Jan; 41(1):85-90. PubMed ID: 1734938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
    Numazawa M; Yoshimura A; Oshibe M
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
    Numazawa M; Kamiyama T; Tachibana M; Oshibe M
    J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.